nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.134	0.614	CbGaD
Carbinoxamine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.124	0.418	CrCrCtD
Carbinoxamine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.111	0.376	CrCrCtD
Carbinoxamine—CYP3A4—type 2 diabetes mellitus	0.0841	0.386	CbGaD
Carbinoxamine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.0608	0.206	CrCrCtD
Carbinoxamine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0198	0.0544	CbGbCtD
Carbinoxamine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0158	0.0435	CbGbCtD
Carbinoxamine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0143	0.0393	CbGbCtD
Carbinoxamine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0141	0.0388	CbGbCtD
Carbinoxamine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0138	0.0379	CbGbCtD
Carbinoxamine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0132	0.0363	CbGbCtD
Carbinoxamine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0127	0.0351	CbGbCtD
Carbinoxamine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0126	0.0347	CbGbCtD
Carbinoxamine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.012	0.033	CbGbCtD
Carbinoxamine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.012	0.033	CbGbCtD
Carbinoxamine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0117	0.0323	CbGbCtD
Carbinoxamine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0111	0.0305	CbGbCtD
Carbinoxamine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0107	0.0294	CbGbCtD
Carbinoxamine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0104	0.0286	CbGbCtD
Carbinoxamine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00997	0.0274	CbGbCtD
Carbinoxamine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00997	0.0274	CbGbCtD
Carbinoxamine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0092	0.0253	CbGbCtD
Carbinoxamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00911	0.0251	CbGbCtD
Carbinoxamine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00899	0.0248	CbGbCtD
Carbinoxamine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00888	0.0245	CbGbCtD
Carbinoxamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00841	0.0232	CbGbCtD
Carbinoxamine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00812	0.0224	CbGbCtD
Carbinoxamine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00802	0.0221	CbGbCtD
Carbinoxamine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00755	0.0208	CbGbCtD
Carbinoxamine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00733	0.0202	CbGbCtD
Carbinoxamine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00724	0.0199	CbGbCtD
Carbinoxamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00691	0.019	CbGbCtD
Carbinoxamine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00669	0.0184	CbGbCtD
Carbinoxamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00662	0.0182	CbGbCtD
Carbinoxamine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00641	0.0176	CbGbCtD
Carbinoxamine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00614	0.0169	CbGbCtD
Carbinoxamine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0058	0.016	CbGbCtD
Carbinoxamine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00561	0.0155	CbGbCtD
Carbinoxamine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0051	0.014	CbGbCtD
Carbinoxamine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00467	0.0128	CbGbCtD
Carbinoxamine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00439	0.0121	CbGbCtD
Carbinoxamine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00421	0.0116	CbGbCtD
Carbinoxamine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00421	0.0116	CbGbCtD
Carbinoxamine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00398	0.011	CbGbCtD
Carbinoxamine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00297	0.00817	CbGbCtD
Carbinoxamine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00271	0.00747	CbGbCtD
Carbinoxamine—Mitotane—CYP11A1—type 2 diabetes mellitus	0.000432	0.219	CrCbGaD
Carbinoxamine—Mitotane—SHBG—type 2 diabetes mellitus	0.000304	0.154	CrCbGaD
Carbinoxamine—Captodiame—HTR2C—type 2 diabetes mellitus	0.000219	0.111	CrCbGaD
Carbinoxamine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000185	0.00218	CcSEcCtD
Carbinoxamine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000185	0.00217	CcSEcCtD
Carbinoxamine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000184	0.00216	CcSEcCtD
Carbinoxamine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00215	CcSEcCtD
Carbinoxamine—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000182	0.00214	CcSEcCtD
Carbinoxamine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00214	CcSEcCtD
Carbinoxamine—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00214	CcSEcCtD
Carbinoxamine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000181	0.00213	CcSEcCtD
Carbinoxamine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00212	CcSEcCtD
Carbinoxamine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00018	0.00211	CcSEcCtD
Carbinoxamine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000179	0.00211	CcSEcCtD
Carbinoxamine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000179	0.0021	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000179	0.0021	CcSEcCtD
Carbinoxamine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00209	CcSEcCtD
Carbinoxamine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000177	0.00208	CcSEcCtD
Carbinoxamine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000176	0.00207	CcSEcCtD
Carbinoxamine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000176	0.00207	CcSEcCtD
Carbinoxamine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000174	0.00205	CcSEcCtD
Carbinoxamine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000174	0.00205	CcSEcCtD
Carbinoxamine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00204	CcSEcCtD
Carbinoxamine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00203	CcSEcCtD
Carbinoxamine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000172	0.00203	CcSEcCtD
Carbinoxamine—Headache—Repaglinide—type 2 diabetes mellitus	0.000171	0.00202	CcSEcCtD
Carbinoxamine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00201	CcSEcCtD
Carbinoxamine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000171	0.00201	CcSEcCtD
Carbinoxamine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000171	0.00201	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00017	0.00201	CcSEcCtD
Carbinoxamine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00017	0.002	CcSEcCtD
Carbinoxamine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00199	CcSEcCtD
Carbinoxamine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000169	0.00199	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000168	0.00198	CcSEcCtD
Carbinoxamine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000168	0.00197	CcSEcCtD
Carbinoxamine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00197	CcSEcCtD
Carbinoxamine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00197	CcSEcCtD
Carbinoxamine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000166	0.00195	CcSEcCtD
Carbinoxamine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000166	0.00195	CcSEcCtD
Carbinoxamine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000166	0.00195	CcSEcCtD
Carbinoxamine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00195	CcSEcCtD
Carbinoxamine—Chills—Metformin—type 2 diabetes mellitus	0.000165	0.00194	CcSEcCtD
Carbinoxamine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00193	CcSEcCtD
Carbinoxamine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000164	0.00193	CcSEcCtD
Carbinoxamine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00192	CcSEcCtD
Carbinoxamine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000163	0.00191	CcSEcCtD
Carbinoxamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000162	0.00191	CcSEcCtD
Carbinoxamine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000162	0.00191	CcSEcCtD
Carbinoxamine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000162	0.00191	CcSEcCtD
Carbinoxamine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000162	0.00191	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.00016	0.00188	CcSEcCtD
Carbinoxamine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000158	0.00186	CcSEcCtD
Carbinoxamine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000158	0.00185	CcSEcCtD
Carbinoxamine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Carbinoxamine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000156	0.00184	CcSEcCtD
Carbinoxamine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000156	0.00184	CcSEcCtD
Carbinoxamine—Chills—Irbesartan—type 2 diabetes mellitus	0.000156	0.00183	CcSEcCtD
Carbinoxamine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000156	0.00183	CcSEcCtD
Carbinoxamine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000156	0.00183	CcSEcCtD
Carbinoxamine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000155	0.00182	CcSEcCtD
Carbinoxamine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000154	0.00181	CcSEcCtD
Carbinoxamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000154	0.00181	CcSEcCtD
Carbinoxamine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000153	0.0018	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000153	0.0018	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000153	0.0018	CcSEcCtD
Carbinoxamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000153	0.0018	CcSEcCtD
Carbinoxamine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000152	0.00179	CcSEcCtD
Carbinoxamine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Carbinoxamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000151	0.00177	CcSEcCtD
Carbinoxamine—Tremor—Metformin—type 2 diabetes mellitus	0.00015	0.00177	CcSEcCtD
Carbinoxamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00015	0.00176	CcSEcCtD
Carbinoxamine—Tension—Irbesartan—type 2 diabetes mellitus	0.000148	0.00175	CcSEcCtD
Carbinoxamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000148	0.00174	CcSEcCtD
Carbinoxamine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000147	0.00173	CcSEcCtD
Carbinoxamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000146	0.00172	CcSEcCtD
Carbinoxamine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000146	0.00172	CcSEcCtD
Carbinoxamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000144	0.0017	CcSEcCtD
Carbinoxamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000144	0.00169	CcSEcCtD
Carbinoxamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000144	0.00169	CcSEcCtD
Carbinoxamine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000143	0.00169	CcSEcCtD
Carbinoxamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00169	CcSEcCtD
Carbinoxamine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000143	0.00168	CcSEcCtD
Carbinoxamine—Headache—Glipizide—type 2 diabetes mellitus	0.000142	0.00167	CcSEcCtD
Carbinoxamine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000142	0.00167	CcSEcCtD
Carbinoxamine—Palpitations—Metformin—type 2 diabetes mellitus	0.000142	0.00167	CcSEcCtD
Carbinoxamine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000141	0.00166	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000141	0.00165	CcSEcCtD
Carbinoxamine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00014	0.00165	CcSEcCtD
Carbinoxamine—Tension—Losartan—type 2 diabetes mellitus	0.00014	0.00164	CcSEcCtD
Carbinoxamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00014	0.00164	CcSEcCtD
Carbinoxamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00164	CcSEcCtD
Carbinoxamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000139	0.00164	CcSEcCtD
Carbinoxamine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000139	0.00164	CcSEcCtD
Carbinoxamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000138	0.00163	CcSEcCtD
Carbinoxamine—Nervousness—Losartan—type 2 diabetes mellitus	0.000138	0.00163	CcSEcCtD
Carbinoxamine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000138	0.00162	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000137	0.00161	CcSEcCtD
Carbinoxamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000137	0.00161	CcSEcCtD
Carbinoxamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000137	0.00161	CcSEcCtD
Carbinoxamine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000136	0.0016	CcSEcCtD
Carbinoxamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000136	0.0016	CcSEcCtD
Carbinoxamine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000135	0.00159	CcSEcCtD
Carbinoxamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000134	0.00158	CcSEcCtD
Carbinoxamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000134	0.00158	CcSEcCtD
Carbinoxamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000134	0.00158	CcSEcCtD
Carbinoxamine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000134	0.00158	CcSEcCtD
Carbinoxamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Carbinoxamine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Carbinoxamine—Tremor—Losartan—type 2 diabetes mellitus	0.000133	0.00157	CcSEcCtD
Carbinoxamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000132	0.00156	CcSEcCtD
Carbinoxamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00155	CcSEcCtD
Carbinoxamine—Agitation—Losartan—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Carbinoxamine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Carbinoxamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00013	0.00153	CcSEcCtD
Carbinoxamine—Insomnia—Valsartan—type 2 diabetes mellitus	0.00013	0.00153	CcSEcCtD
Carbinoxamine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000129	0.00152	CcSEcCtD
Carbinoxamine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000129	0.00152	CcSEcCtD
Carbinoxamine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000128	0.00151	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000128	0.00151	CcSEcCtD
Carbinoxamine—Vertigo—Losartan—type 2 diabetes mellitus	0.000128	0.0015	CcSEcCtD
Carbinoxamine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000128	0.0015	CcSEcCtD
Carbinoxamine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000127	0.0015	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000126	0.00149	CcSEcCtD
Carbinoxamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000126	0.00149	CcSEcCtD
Carbinoxamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00148	CcSEcCtD
Carbinoxamine—Palpitations—Losartan—type 2 diabetes mellitus	0.000126	0.00148	CcSEcCtD
Carbinoxamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000125	0.00148	CcSEcCtD
Carbinoxamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Carbinoxamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Carbinoxamine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Carbinoxamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Carbinoxamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Carbinoxamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000124	0.00146	CcSEcCtD
Carbinoxamine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000124	0.00146	CcSEcCtD
Carbinoxamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000123	0.00145	CcSEcCtD
Carbinoxamine—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.00145	CcSEcCtD
Carbinoxamine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000122	0.00144	CcSEcCtD
Carbinoxamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000122	0.00144	CcSEcCtD
Carbinoxamine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.000122	0.0618	CrCbGaD
Carbinoxamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000121	0.00142	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000121	0.00142	CcSEcCtD
Carbinoxamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00012	0.00142	CcSEcCtD
Carbinoxamine—Tension—Ramipril—type 2 diabetes mellitus	0.00012	0.00141	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Carbinoxamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Carbinoxamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Carbinoxamine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000119	0.00139	CcSEcCtD
Carbinoxamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00138	CcSEcCtD
Carbinoxamine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000117	0.00138	CcSEcCtD
Carbinoxamine—Confusional state—Losartan—type 2 diabetes mellitus	0.000117	0.00138	CcSEcCtD
Carbinoxamine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000117	0.00138	CcSEcCtD
Carbinoxamine—Somnolence—Metformin—type 2 diabetes mellitus	0.000116	0.00137	CcSEcCtD
Carbinoxamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000115	0.00136	CcSEcCtD
Carbinoxamine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Carbinoxamine—Tremor—Ramipril—type 2 diabetes mellitus	0.000114	0.00135	CcSEcCtD
Carbinoxamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000114	0.00134	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000114	0.00134	CcSEcCtD
Carbinoxamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000114	0.00134	CcSEcCtD
Carbinoxamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000113	0.00133	CcSEcCtD
Carbinoxamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00133	CcSEcCtD
Carbinoxamine—Fatigue—Metformin—type 2 diabetes mellitus	0.000113	0.00133	CcSEcCtD
Carbinoxamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000113	0.00133	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000112	0.00132	CcSEcCtD
Carbinoxamine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000112	0.00132	CcSEcCtD
Carbinoxamine—Agitation—Ramipril—type 2 diabetes mellitus	0.000112	0.00132	CcSEcCtD
Carbinoxamine—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.00132	CcSEcCtD
Carbinoxamine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Carbinoxamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Carbinoxamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Carbinoxamine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00011	0.00129	CcSEcCtD
Carbinoxamine—Vertigo—Ramipril—type 2 diabetes mellitus	0.00011	0.00129	CcSEcCtD
Carbinoxamine—Headache—Glyburide—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Carbinoxamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Carbinoxamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Carbinoxamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000108	0.00127	CcSEcCtD
Carbinoxamine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000108	0.00127	CcSEcCtD
Carbinoxamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000107	0.00126	CcSEcCtD
Carbinoxamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.00126	CcSEcCtD
Carbinoxamine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000106	0.00125	CcSEcCtD
Carbinoxamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000106	0.00124	CcSEcCtD
Carbinoxamine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.00124	CcSEcCtD
Carbinoxamine—Insomnia—Losartan—type 2 diabetes mellitus	0.000105	0.00124	CcSEcCtD
Carbinoxamine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000104	0.00123	CcSEcCtD
Carbinoxamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000104	0.00122	CcSEcCtD
Carbinoxamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000103	0.00122	CcSEcCtD
Carbinoxamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000103	0.00122	CcSEcCtD
Carbinoxamine—Somnolence—Losartan—type 2 diabetes mellitus	0.000103	0.00122	CcSEcCtD
Carbinoxamine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000103	0.00121	CcSEcCtD
Carbinoxamine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000102	0.0012	CcSEcCtD
Carbinoxamine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000102	0.0012	CcSEcCtD
Carbinoxamine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.0012	CcSEcCtD
Carbinoxamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000101	0.00119	CcSEcCtD
Carbinoxamine—Confusional state—Ramipril—type 2 diabetes mellitus	0.0001	0.00118	CcSEcCtD
Carbinoxamine—Fatigue—Losartan—type 2 diabetes mellitus	0.0001	0.00118	CcSEcCtD
Carbinoxamine—Vomiting—Gliclazide—type 2 diabetes mellitus	9.94e-05	0.00117	CcSEcCtD
Carbinoxamine—Constipation—Losartan—type 2 diabetes mellitus	9.93e-05	0.00117	CcSEcCtD
Carbinoxamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.83e-05	0.00116	CcSEcCtD
Carbinoxamine—Urticaria—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00115	CcSEcCtD
Carbinoxamine—Headache—Gliclazide—type 2 diabetes mellitus	9.79e-05	0.00115	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.75e-05	0.00115	CcSEcCtD
Carbinoxamine—Tachycardia—Ramipril—type 2 diabetes mellitus	9.72e-05	0.00114	CcSEcCtD
Carbinoxamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.71e-05	0.00114	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.63e-05	0.00113	CcSEcCtD
Carbinoxamine—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.57e-05	0.00113	CcSEcCtD
Carbinoxamine—Dizziness—Valsartan—type 2 diabetes mellitus	9.5e-05	0.00112	CcSEcCtD
Carbinoxamine—Anorexia—Ramipril—type 2 diabetes mellitus	9.5e-05	0.00112	CcSEcCtD
Carbinoxamine—Dizziness—Orlistat—type 2 diabetes mellitus	9.39e-05	0.0011	CcSEcCtD
Carbinoxamine—Asthenia—Metformin—type 2 diabetes mellitus	9.39e-05	0.0011	CcSEcCtD
Carbinoxamine—Hypotension—Ramipril—type 2 diabetes mellitus	9.31e-05	0.0011	CcSEcCtD
Carbinoxamine—Nausea—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.00109	CcSEcCtD
Carbinoxamine—Urticaria—Losartan—type 2 diabetes mellitus	9.23e-05	0.00109	CcSEcCtD
Carbinoxamine—Vomiting—Valsartan—type 2 diabetes mellitus	9.13e-05	0.00107	CcSEcCtD
Carbinoxamine—Vomiting—Orlistat—type 2 diabetes mellitus	9.02e-05	0.00106	CcSEcCtD
Carbinoxamine—Insomnia—Ramipril—type 2 diabetes mellitus	9.01e-05	0.00106	CcSEcCtD
Carbinoxamine—Headache—Valsartan—type 2 diabetes mellitus	9e-05	0.00106	CcSEcCtD
Carbinoxamine—Diarrhoea—Metformin—type 2 diabetes mellitus	8.95e-05	0.00105	CcSEcCtD
Carbinoxamine—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.94e-05	0.00105	CcSEcCtD
Carbinoxamine—Headache—Orlistat—type 2 diabetes mellitus	8.89e-05	0.00105	CcSEcCtD
Carbinoxamine—Asthenia—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.00104	CcSEcCtD
Carbinoxamine—Somnolence—Ramipril—type 2 diabetes mellitus	8.86e-05	0.00104	CcSEcCtD
Carbinoxamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.77e-05	0.00103	CcSEcCtD
Carbinoxamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.66e-05	0.00102	CcSEcCtD
Carbinoxamine—Dizziness—Metformin—type 2 diabetes mellitus	8.65e-05	0.00102	CcSEcCtD
Carbinoxamine—Fatigue—Ramipril—type 2 diabetes mellitus	8.59e-05	0.00101	CcSEcCtD
Carbinoxamine—Nausea—Valsartan—type 2 diabetes mellitus	8.53e-05	0.001	CcSEcCtD
Carbinoxamine—Constipation—Ramipril—type 2 diabetes mellitus	8.52e-05	0.001	CcSEcCtD
Carbinoxamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000994	CcSEcCtD
Carbinoxamine—Nausea—Orlistat—type 2 diabetes mellitus	8.43e-05	0.000992	CcSEcCtD
Carbinoxamine—Asthenia—Losartan—type 2 diabetes mellitus	8.34e-05	0.000981	CcSEcCtD
Carbinoxamine—Vomiting—Metformin—type 2 diabetes mellitus	8.32e-05	0.000979	CcSEcCtD
Carbinoxamine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000966	CcSEcCtD
Carbinoxamine—Headache—Metformin—type 2 diabetes mellitus	8.19e-05	0.000964	CcSEcCtD
Carbinoxamine—Dizziness—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000961	CcSEcCtD
Carbinoxamine—Clomipramine—ADRA2A—type 2 diabetes mellitus	8.05e-05	0.0408	CrCbGaD
Carbinoxamine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	7.97e-05	0.0404	CrCbGaD
Carbinoxamine—Diarrhoea—Losartan—type 2 diabetes mellitus	7.95e-05	0.000935	CcSEcCtD
Carbinoxamine—Urticaria—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000931	CcSEcCtD
Carbinoxamine—Vomiting—Irbesartan—type 2 diabetes mellitus	7.85e-05	0.000924	CcSEcCtD
Carbinoxamine—Nausea—Metformin—type 2 diabetes mellitus	7.77e-05	0.000914	CcSEcCtD
Carbinoxamine—Headache—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.00091	CcSEcCtD
Carbinoxamine—Dizziness—Losartan—type 2 diabetes mellitus	7.68e-05	0.000904	CcSEcCtD
Carbinoxamine—Clomipramine—HTR2C—type 2 diabetes mellitus	7.41e-05	0.0375	CrCbGaD
Carbinoxamine—Vomiting—Losartan—type 2 diabetes mellitus	7.39e-05	0.000869	CcSEcCtD
Carbinoxamine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	7.38e-05	0.0374	CrCbGaD
Carbinoxamine—Nausea—Irbesartan—type 2 diabetes mellitus	7.33e-05	0.000863	CcSEcCtD
Carbinoxamine—Headache—Losartan—type 2 diabetes mellitus	7.28e-05	0.000856	CcSEcCtD
Carbinoxamine—Asthenia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000841	CcSEcCtD
Carbinoxamine—Nausea—Losartan—type 2 diabetes mellitus	6.9e-05	0.000812	CcSEcCtD
Carbinoxamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000802	CcSEcCtD
Carbinoxamine—Dizziness—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000775	CcSEcCtD
Carbinoxamine—Vomiting—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000745	CcSEcCtD
Carbinoxamine—Headache—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000734	CcSEcCtD
Carbinoxamine—Nausea—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000696	CcSEcCtD
Carbinoxamine—Clomipramine—CYP1A2—type 2 diabetes mellitus	5.59e-05	0.0283	CrCbGaD
Carbinoxamine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	5.52e-05	0.028	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	5.08e-05	0.0257	CrCbGaD
Carbinoxamine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	5.05e-05	0.0256	CrCbGaD
Carbinoxamine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	5.02e-05	0.0254	CrCbGaD
Carbinoxamine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	5.02e-05	0.0254	CrCbGaD
Carbinoxamine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	4.93e-05	0.025	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	4.03e-05	0.0204	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	3.84e-05	0.0194	CrCbGaD
Carbinoxamine—Clomipramine—CYP3A4—type 2 diabetes mellitus	3.7e-05	0.0188	CrCbGaD
Carbinoxamine—Clomipramine—ALB—type 2 diabetes mellitus	3.23e-05	0.0164	CrCbGaD
Carbinoxamine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	3.16e-05	0.016	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	2.54e-05	0.0129	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—type 2 diabetes mellitus	2.21e-05	0.0112	CrCbGaD
Carbinoxamine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.89e-06	0.000107	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.89e-06	0.000107	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.89e-06	0.000107	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.87e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.86e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.86e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.85e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	3.84e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	3.83e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.82e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.82e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.79e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.76e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	3.76e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	3.76e-06	0.000103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.76e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	3.75e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.74e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.74e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.73e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.73e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.7e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.7e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.7e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.68e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.68e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.67e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	3.65e-06	0.0001	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.61e-06	9.87e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.6e-06	9.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.6e-06	9.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.6e-06	9.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.6e-06	9.86e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.59e-06	9.83e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.58e-06	9.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.57e-06	9.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.57e-06	9.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.56e-06	9.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.56e-06	9.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.55e-06	9.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.55e-06	9.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.53e-06	9.67e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.53e-06	9.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.52e-06	9.64e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.52e-06	9.64e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.51e-06	9.61e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.46e-06	9.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.46e-06	9.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.46e-06	9.47e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.45e-06	9.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.43e-06	9.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.41e-06	9.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.41e-06	9.33e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.4e-06	9.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.4e-06	9.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.39e-06	9.29e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.39e-06	9.28e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	3.38e-06	9.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.37e-06	9.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.37e-06	9.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.32e-06	9.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.31e-06	9.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.29e-06	9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.25e-06	8.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.23e-06	8.85e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.23e-06	8.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.22e-06	8.82e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.22e-06	8.82e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.22e-06	8.82e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.22e-06	8.81e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.21e-06	8.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.19e-06	8.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.19e-06	8.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.18e-06	8.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.18e-06	8.72e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-06	8.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.17e-06	8.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.17e-06	8.67e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.16e-06	8.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.15e-06	8.64e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.15e-06	8.63e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.15e-06	8.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.13e-06	8.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.12e-06	8.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.11e-06	8.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.09e-06	8.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.05e-06	8.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.04e-06	8.33e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3e-06	8.21e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.97e-06	8.14e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.96e-06	8.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.94e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.94e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.93e-06	8.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.93e-06	8.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.93e-06	8.02e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.92e-06	8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.91e-06	7.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.91e-06	7.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.9e-06	7.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.89e-06	7.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.88e-06	7.89e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.88e-06	7.88e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.87e-06	7.87e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.86e-06	7.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.86e-06	7.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.86e-06	7.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.86e-06	7.82e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.84e-06	7.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-06	7.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-06	7.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.81e-06	7.7e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.81e-06	7.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.8e-06	7.66e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.79e-06	7.65e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.78e-06	7.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.77e-06	7.59e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.76e-06	7.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.76e-06	7.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.75e-06	7.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.75e-06	7.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.74e-06	7.49e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.73e-06	7.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-06	7.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.72e-06	7.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.7e-06	7.39e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.7e-06	7.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.7e-06	7.38e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	2.69e-06	7.37e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.67e-06	7.31e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.65e-06	7.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.65e-06	7.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.61e-06	7.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-06	7.16e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.61e-06	7.14e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.6e-06	7.13e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.6e-06	7.12e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.59e-06	7.1e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.59e-06	7.09e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.58e-06	7.07e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.57e-06	7.03e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.57e-06	7.03e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.57e-06	7.03e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.57e-06	7.02e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.54e-06	6.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	6.91e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.52e-06	6.9e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.52e-06	6.89e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.51e-06	6.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.5e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.48e-06	6.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.48e-06	6.8e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.47e-06	6.77e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	6.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.44e-06	6.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	6.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.43e-06	6.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	6.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	6.61e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.41e-06	6.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.4e-06	6.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.38e-06	6.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.38e-06	6.5e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	6.47e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.36e-06	6.46e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.36e-06	6.46e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.36e-06	6.46e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.35e-06	6.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.34e-06	6.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.33e-06	6.38e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.32e-06	6.36e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.32e-06	6.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.28e-06	6.26e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.27e-06	6.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-06	6.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.24e-06	6.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.23e-06	6.1e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.23e-06	6.09e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.23e-06	6.09e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.22e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.22e-06	6.08e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.21e-06	6.06e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.21e-06	6.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.19e-06	6.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	5.92e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.14e-06	5.85e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-06	5.81e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.08e-06	5.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.04e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.04e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.02e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2e-06	5.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.99e-06	5.45e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.95e-06	5.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-06	5.29e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.92e-06	5.25e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.92e-06	5.25e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.91e-06	5.24e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.91e-06	5.23e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.91e-06	5.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	5.19e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.89e-06	5.19e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.88e-06	5.16e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.87e-06	5.13e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.87e-06	5.12e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.84e-06	5.03e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.83e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-06	4.99e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.78e-06	4.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	4.8e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.75e-06	4.78e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.75e-06	4.78e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.74e-06	4.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.71e-06	4.68e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.7e-06	4.66e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.7e-06	4.66e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-06	4.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-06	4.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	4.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-06	4.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-06	4.55e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.66e-06	4.54e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.64e-06	4.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.57e-06	4.31e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.56e-06	4.27e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.54e-06	4.22e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	4.2e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.53e-06	4.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.52e-06	4.16e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.49e-06	4.09e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.47e-06	4.02e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.46e-06	4.01e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.45e-06	3.96e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.27e-06	3.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.25e-06	3.42e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.18e-06	3.22e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.15e-06	3.14e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	3.04e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.1e-06	3e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.1e-06	3e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	2.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	2.97e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1e-06	2.75e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	9.39e-07	2.57e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.38e-07	2.3e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.71e-07	2.11e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.64e-07	2.09e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.04e-07	1.38e-05	CbGpPWpGaD
